Associate Director, Clinical Supply Chain Planning
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
-
Collaborating with product leads and study managers, will ensure global clinical demand for RevMed and Non Rev-Med commercial products is accurately reflected within the N-side system on a monthly basis as part of DnOP process.
-
Drive business process standardization, implementation, and training on new processes.
-
Lead end-to-end clinical supply planning for assigned clinical programs and studies, from study start-
